Haydale Graphene Ind

Comment on Speculation

RNS Number : 5384Q
Haydale Graphene Industries PLC
20 February 2019
 

 

For immediate release

20 February 2019

 

 

 

Haydale Graphene Industries plc

 

("Haydale" or the "Company")

 

Comment on Speculation

Haydale, (AIM: HAYD), the global advanced materials group, notes speculation regarding the prospect of an imminent equity placing. The Company confirms that it is currently conducting market soundings with potential institutional investors and that any such equity placing is expected to be carried out at a material discount to yesterday's closing price. In line with the Company's previous practice, it is anticipated that a pre-emptive offer would also be made to existing shareholders.

Discussions with potential investors remain ongoing and a detailed announcement will be made in due course.

 

Certain information contained in this announcement would have been deemed inside information for the purposes of Article 7 of Regulation (EU) No 596/2014 until the release of this announcement.

- Ends -

For further information:

Haydale Graphene Industries plc

 

David Banks, Interim Executive Chairman

Tel: +44 (0) 1269 842 946

 

www.haydale.com 

 

 

Arden Partners plc (Nominated Adviser & Broker)

 

Paul Shackleton

Tel: +44 (0) 20 7614 5900

 

Notes to Editors

Haydale is a global technologies and materials group that facilitates the integration of graphene and other nanomaterials into the next generation of commercial technologies and industrial materials.  With expertise in graphene, silicon carbide and other nanomaterials, Haydale is able to deliver improvements in electrical, thermal and mechanical properties, as well as toughness.  Haydale has granted patents for its technologies in Europe, USA, Australia, Japan and China and operates from six sites in the UK, USA and the Far East.

For more information please visit: www.haydale.com 

Twitter: @haydalegraphene 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
 
END
 
 
STRCKCDPDBKBOBD